Quanterix Inc (QTRX) - Market Capitalization to Book Value Ratio

Quanterix (QTRX) - corporate logo

Production capacities for protein analysis systems are operating at full capacity, and equipment has been upgraded. Quanterix Corporation (QTRX) relies on stable agreements with pharmaceutical corporations, which minimizes cyclical impact, and the current figure stands at 0.58. The price chart for Quanterix Corporation (QTRX) clearly demonstrates the asset's dynamics. However, export restrictions and chip shortages are hindering expansion into Asia and slowing the production of complex instruments.

Quanterix Inc (QTRX) - Market Capitalization to Book Value from 07/04/2022 to 10/31/2026
Flagship merchandise of Quanterix Corp

This indicator expresses the ratio of the current market value of Quanterix Corporation (QTRX) to its total equity, measuring the degree of asset premium or discount relative to their book value. In the context of full capacity utilization for diagnostic system production and the modernization of the machine tool fleet, changes in the revaluation level of balance sheet capital reflect market expectations regarding the future efficiency of the company's high-tech infrastructure.

Analysis of competing companies

ABT (Abbott Laboratories) - Market Cap to Net Assets Ratio|Capitalization to Book Value Ratio TMO|GEHC (GE HealthCare Technologies) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio MTD (Mettler-Toledo)|Market Capitalization to Book Value Ratio WAT|Market Capitalization to Book Value Bio-Techne Inc.|Market Capitalization to Book Value Ratio BRKR (Bruker Corporation)|Market Capitalization to Book Value Ratio azenta.com AZTA|Varex Imaging Corporation - Market Capitalization to Book Value Ratio|Market Value to Equity Ratio Semler Scientific Inc (SMLR)|Butterfly iQ (BFLY) - Market Value to Book Value Ratio|Capitalization to Book Value Ratio MLAB|Market Value to Book Value Ratio Quantum-Si|Market-to-Book Ratio nanox.vision NNOX|Market Value to Book Value Ratio 908 Devices (MASS)|Market Capitalization to Book Value capsovision.com|MaxCyte, Inc - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple RPID (Rapid Micro Biosystems Inc.)|Seer, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value hyperfine.io HYPR|FONR: Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Daxor|Market Cap to Net Assets Ratio MDAI|VIVS: Market Value to Book Value|Market Value to Book Value Ratio Aclarion (ACON)|Market Cap to Net Assets Ratio akoyabio.com AKYA|Market Capitalization to Book Value Ratio THMO (ThermoGenesis Holdings)|Talis Biomedical Corp. (TLIS) - Market-to-Book Ratio|T2 Biosystems, Inc - Market Capitalization to Book Value Ratio